New pill could bring relief to millions with severe eczema
NCT ID NCT07370909
First seen Jan 31, 2026 · Last updated May 22, 2026 · Updated 26 times
Summary
This study tests an experimental oral medication called LW402 for adults with moderate-to-severe atopic dermatitis (eczema). About 480 participants will receive either the drug or a placebo to see if it safely improves skin symptoms like redness and itching. The main goal is to measure at least a 75% reduction in eczema severity after 16 weeks of treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University People's Hospital
Beijing, China
Contact
Conditions
Explore the condition pages connected to this study.